Skip Navigation Links

DSM | Company Information from ICIS

 

DSM is active in nutritional and pharma ingredients, performance materials and industrial chemicals. Its products are used in a wide range of end-markets and applications. DSM's activities are grouped into four clusters: Nutrition, Pharma, Performance Materials and Industrial Chemicals.

 DSM

DSM's new strategy will focus on accelerated growth and expansion of the specialty content of its portfolio, accelerated innovation, and expansion in emerging economies. The overall objective of the strategy is “strong value creation” by market-driven growth

and innovation, increased presence in emerging economies and operational excellence.

 

DSM intends to grow its sales in four emerging business areas; personalised nutrition, specialty packaging, biomedical materials and white/industrial biotechnology. It also intends to further grow the specialty content of its portfolio.

 

The company plans to continue the trend of improving its globally balanced presence by accelerating the internationalisation of its asset base and workforce. DSM has been focussing on China and India and it has also started investigating future possibilities in Russia.

 

DSM has sales of around Euro9bn and around 22,000 employees (2010) with headquarters in Heelen, The Netherlands.

 

Download the The ICIS Top 100 Chemical Companies listing here

 

Key Personnel

 

Chairman: Feike Sijbesma
Member: Nico Gerardu
Member: Stephan Tanda
Member and CFO: Rolf-Dieter Schwalb

Member: Margo Vliegenthart
Chief innovation officer: Rob van Leen

Chief purchasing officer: Tim Tolhurst

Corporate secretary: Femke Weijtens

Chairman (supervisory board): Rob Routs

Member supervisory board: Pauline van der Meer Mohr

Business group director (Dyneema): Gerard de Reuver

Business unit director (NeoResins): Steve Hartig

Business group director (Resins): Dimitri de Vreeze

Executive VP (CHR): Chris Van Steenbergen

President (Biomedica): Christophe Dardel

Chief marketing officer: Mauricio Adade

Senior vice president (emerging business): Anton Robek

Vice president (strategy and growth): Volkert Claassen

President (human nutrition & health and nutritional products): Rick Greubel

President and CEO (DSM Pharmaceutical Products): Alexander Wessels

President and CEO (DSM Food Specialties): Hans Christian Ambjerg

 

Contacts

 

PO Box 6500
6401
JH Heelen
The Netherlands

Tel:  +31 45 578 2422
Fax:  +31 45 574 0608

 

www.dsm.com 

DSM Company Structure

DSM is active in nutritional and pharma ingredients, performance materials and industrial chemicals. DSM’s products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paints, housing and electrics and electronics.
More about DSM Structure

DSM Strategy & Financial Highlights

DSM states that after successfully completing its strategy “Vision 2005 Focus and Value” in 2006, it will focus on its five year strategy of “Vision 2010 Building on Strengths” in 2007. The new strategy will focus on accelerated growth and expansion of the specialty content of its portfolio, accelerated innovation, and expansion in emerging economies. The overall objective of the strategy is “strong value creation”. (Edited from: “Message from the chairman”, “Objectives Vision 2010 – Building on Strengths"). ICIS also provides you with key financial data listed in table form. More about DSM Strategy & Financial Highlights

News:

Get news on DSM plus the latest chemical news, information, data, market movements and analysis in one place with ICIS news

Search:

Find details on other chemical companies and suppliers with ICIS search

Newsletters:

ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.

Plants and projects:

Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database

 
Free trial to ICIS
ICIS Chemical Business - ICIS Chemical Business From Our Own Correspondent
This blog records content for the From Our Own Correspondent column of ICIS Chemical Business ahead of publication. It is a series of works in progress. To read the definitive version of the column subscribe to ICIS Chemical Business on paper and on line

Insight

INSIGHT: Chemical break-ups in vogue; the end of conglomerates
"The shift to accelerate growth through shrinking is already taking place." more

VIDEO: ICIS special report on the fertilizers markets

More...

We welcome your feedback. Please feel free to send us your comments on any aspect of this site. Click here to make your comments.